# EDGAR Filing Document

**Accession Number:** 0001308547
**File Stem:** 0001193125-26-041211
**Filing Date:** 2026-2
**Character Count:** 6301
**Document Hash:** 97f4e9ddd43ede09fc0dc2d28d084836
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-041211.hdr.sgml**: 20260206

**ACCESSION NUMBER**: 0001193125-26-041211

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260203

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20260206

**DATE AS OF CHANGE**: 20260206

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Dolby Laboratories, Inc.
- **CENTRAL INDEX KEY:** 0001308547
- **STANDARD INDUSTRIAL CLASSIFICATION:** PATENT OWNERS & LESSORS [6794]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 900199783
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0927

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-32431
- **FILM NUMBER:** 26607823

**BUSINESS ADDRESS:**
- **STREET 1:** 1275 MARKET STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94103
- **BUSINESS PHONE:** 415 558 0200

**MAIL ADDRESS:**
- **STREET 1:** 1275 MARKET STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94103

?xml version='1.0' encoding='ASCII'? 8-K

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

### FORM 8-K

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d)

#### of The Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported):

#### February 3, 2026

## DOLBY LABORATORIES, INC.

#### (Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-32431** | **90-0199783** |
| **(State or other jurisdiction**<br> **of incorporation)** | **(Commission**<br> **File Number)** | **(IRS Employer**<br> **Identification No.)** |

---

#### 1275 Market Street

#### San Francisco, CA 94103-1410

#### (Address of principal executive offices) (Zip Code)
(415) 558-0200

#### (Registrant's telephone number, including area code)

#### Not Applicable

#### (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | |
|:---|:---|
| **Title of each class** | **Name of each exchange**<br> **on which registered** |
| Class A common stock, $0.001 par value DLB | The New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 5.07.** | **Submission of Matters to a Vote of Security Holders.**  |

---

<u>5.07(a) and (b)</u> 

At the Dolby Laboratories, Inc. (the "Company") 2026 Annual Meeting of Stockholders (the "Annual Meeting"), held on February 3, 2026 via live webcast, the Company's stockholders:

1. Elected eight directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified;

2. Approved an advisory vote to approve the compensation of the Company's named executive officers; and

3. Ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending September 25, 2026.

Each share of the Company's Class A common stock is entitled to one vote, and each share of the Company's Class B common stock is entitled to ten votes, on all matters submitted to a vote of stockholders at the Annual Meeting. The Class A common stock and Class B common stock vote together as a single class on all matters submitted to a vote of stockholders, except as may otherwise be required by law. At the Annual Meeting, the holders of Class A common stock and Class B common stock voted as follows:

**Proposal 1** - Election of directors:

---

| | | | |
|:---|:---|:---|:---|
| **Director** | **Votes For** | **Votes Withheld** | **Broker Non-Votes** |
| Kevin Yeaman | 398050627 | 1048153 | 3884937 |
| Peter Gotcher | 378298036 | 20800744 | 3884937 |
| David Dolby | 385278560 | 13820220 | 3884937 |
| Tony Prophet | 398279483 | 819297 | 3884937 |
| Emily Rollins | 398301201 | 797579 | 3884937 |
| Simon Segars | 385219594 | 13879186 | 3884937 |
| Anjali Sud | 398258221 | 840559 | 3884937 |
| Avadis Tevanian, Jr. | 384798223 | 14300557 | 3884937 |

---

All director nominees were duly elected.

**Proposal 2** - Approval of an advisory vote to approve the compensation of the Company's named executive officers:

---

| | | | |
|:---|:---|:---|:---|
| **Votes For** | **Votes Against** | **Abstentions** | **Broker Non-Votes** |
| 396794929 | 2216964 | 86887 | 3884937 |

---

Proposal 2 was approved.

**Proposal 3** - Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending September 25, 2026:

---

| | | |
|:---|:---|:---|
| **Votes For** | **Votes Against** | **Abstentions** |
| 400209219 | 2718973 | 55525 |

---

Proposal 3 was approved.

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| **DOLBY LABORATORIES, INC.** | **DOLBY LABORATORIES, INC.** |
| By: | /s/ ANDY SHERMAN |
|  | Andy Sherman |
|  | Executive Vice President, General Counsel and Corporate Secretary |

---

Date: February 6, 2026